These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

615 related items for PubMed ID: 15329205

  • 1. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS, Wang BE, Wang TL, Jia JD, Qian LX.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
    [Abstract] [Full Text] [Related]

  • 2. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH, Park CK, Kim ES, Park SY, Jo CM, Tak WY, Kweon YO, Kim SK, Choi YW.
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [Abstract] [Full Text] [Related]

  • 3. [The relationship of serum metalloproteinase with the severity of liver fibrosis and inflammation].
    Yin SS, Li XM, Wang BE, Wang TL, Jia JD, Qian LX.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):666-8. PubMed ID: 15623375
    [Abstract] [Full Text] [Related]

  • 4. [The value of serum markers in evaluating liver fibrotic changes].
    Hu YY, Liu P, Liu C, Liu CH, Xu LM.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):174-7. PubMed ID: 16556409
    [Abstract] [Full Text] [Related]

  • 5. [Serum markers and pathological evaluation in hepatitis fibrosis of chronic hepatitis B treated with interferon alpha].
    Deng L, Zhou Y, Peng X, Deng H, Deng Y, Yao J.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():66-7. PubMed ID: 11509145
    [Abstract] [Full Text] [Related]

  • 6. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].
    Chen YP, Feng XR, Dai L, Ding HB, Zhang L.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522
    [Abstract] [Full Text] [Related]

  • 7. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
    Ding XJ, Li SB, Li SZ, Liu HS, Liu B, Xu FM, Gu RW.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
    [Abstract] [Full Text] [Related]

  • 8. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis.
    Xie SB, Yao JL, Zheng RQ, Peng XM, Gao ZL.
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):69-72. PubMed ID: 14607650
    [Abstract] [Full Text] [Related]

  • 9. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A, Deulofeu R, Giménez A, Caballería L, Bruguera M, Caballería J, Ballesta AM, Rodés J.
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [Abstract] [Full Text] [Related]

  • 10. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H, Rahimipour A, Nouri M, Somi MH, Qujeq D, Fard MK, Agcheli K.
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
    [Abstract] [Full Text] [Related]

  • 11. Assessment of liver fibrosis development in chronic hepatitis B patients by serum hyaluronic acid and laminin levels.
    Parsian H, Rahimipour A, Nouri M, Somi MH, Qujeq D.
    Acta Clin Croat; 2010 Sep; 49(3):257-65. PubMed ID: 21462814
    [Abstract] [Full Text] [Related]

  • 12. [The clinical study on chronic hepatitis B treated by the four-step therapeutics of Traditional Chinese Medicine].
    Yang HZ, Wang FL, Wang YZ, Shen WS, Xu GL, Yang YW, Huang XL.
    Zhong Yao Cai; 2006 Jul; 29(7):748-52. PubMed ID: 17059015
    [Abstract] [Full Text] [Related]

  • 13. [Study on the influence factors of the serum fibrosis markers].
    Cai WM, Tao J, Weng HL, Liu RH.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):23-5. PubMed ID: 12546736
    [Abstract] [Full Text] [Related]

  • 14. [Supplemental Fuzhenghuayu capsule therapy for improving liver fibrosis markers in patients with chronic hepatitis B following unsatisfactory outcome of nucleos(t)ide analogue monotherapy].
    Tian YL, Zhu XY, Yin WW, Zang ZD, Wang L, Fu XL.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jul; 21(7):514-8. PubMed ID: 24074710
    [Abstract] [Full Text] [Related]

  • 15. [Clinical study on treatment of cirrhosis by different dosages of salvia injection].
    Ye F, Liu Y, Qiu G, Zhao Y, Liu M.
    Zhong Yao Cai; 2005 Sep; 28(9):850-4. PubMed ID: 16447879
    [Abstract] [Full Text] [Related]

  • 16. [Relationship between serum HBV DNA levels and hepatic fibrosis markers in chronic hepatitis B].
    Dong Z, Shen H, Zhang FK.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):129-31. PubMed ID: 17653313
    [Abstract] [Full Text] [Related]

  • 17. [Diagnostic value of five serum markers for liver fibrosis].
    Luo R, Yang S, Xie J, Zhao Z, He Y, Yao J.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
    [Abstract] [Full Text] [Related]

  • 18. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
    Ding H, Chen Y, Feng X, Liu D, Wu A, Zhang L.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
    [Abstract] [Full Text] [Related]

  • 19. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance.
    Zheng M, Cai W, Weng H, Liu R.
    Chin Med J (Engl); 2003 Mar; 116(3):346-9. PubMed ID: 12781034
    [Abstract] [Full Text] [Related]

  • 20. [The clinical study on decompensatory cirrhotic patients treated by Bie Jia Jian].
    Wang YZ, Yang HZ, Lin BL, Xie HP, Li YW, Dai M.
    Zhong Yao Cai; 2007 Jun; 30(6):755-7. PubMed ID: 17918451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.